[Myelostimulating effects of a thymus extract in patients undergoing a sequential antineoplastic chemotherapy].
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D001853:Bone Marrow / Q000187:drug effects*; D001999:Bronchoscopy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D012075:Remission, Spontaneous; D013949:Thymus Extracts / Q000494:pharmacology*; D014056:Tomography, X-Ray; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013949:Thymus Extracts; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D008727:Methotrexate
Valutazione degli effetti mielostimolanti di un estratto di timo in pazienti trattati con chemioterapia antineoplastica sequenziale